Final pathology confirmed a 2 mm invasive ductal carcinoma, estrogen receptor (ER) + (95%) and progesterone receptor (PR) + (80%); HER2 status could not be determined due to insufficient tissue for testing. This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.